Concentric launches next-generation Merci neurovascular retrievers
This article was originally published in Clinica
Concentric Medical has launched its V series of Merci neurovascular retrievers in the US. The Merci Retriever system, first approved in the US in 2004, removes blood clots from patients experiencing ischaemic stroke. The new series is designed to be the most efficient yet, claims Mountain View, California-based Concentric. The retrievers will be available in 2.0, 2.5 and 3.0mm diameters. The V series of retrievers incorporate filaments to help secure blood clots, similar to the L series, cleared in the US in 2007.